The International Drug Policy Consortium (IDPC) is a network of +190 NGOs – including dozens of European NGOs – that seek to reform drug policies in order to advance social justice and human rights. IDPC welcomes a renewed mandate for the EMCDDA, as it plays a critical role in supporting evidence-based drug policies across the EU, and more broadly globally.
IDP
International Drug Policy Consortium
NGO · Netherlands · EU Transparency Register 75318797051-52
3
positions filed
in the 665 files tracked
2
legislative files
of 665 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1106 non-governmental organisations on this site, they rank #523 by legislative files engaged, a count of participation, not a measure of influence.
5.5
declared lobbying FTE
self-declared
–
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2011
in the register since
Declares membership of
- IDPC is a member of the European Civil Society Forum on Drugs, the Vienna NGO Committee on Drugs, the New York NGO Co…
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Non-governmental organisations
- Head office
- Amsterdam, Netherlands
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track International in PolicySpeak: request access →
Work at International Drug Policy Consortium? so we know who speaks for it.
Their record over time
International Drug Policy Consortium filed 3 positions between 29 Jul 2020 and 12 Feb 2025, across 2 of the 665 legislative files tracked here, attaching a full position paper 1 time.
2020 · 1 filed2022 · 1 filed2025 · 1 filed
What they argued
The International Drug Policy Consortium (IDPC), a network of over 195 NGOs promoting drug policy reform on the basis of public health, human rights, and social justice, welcomes the opportunity to provide feedback to the Inception Impact Assessment concerning the revision of the mandate of the European Monitoring Centre for Drugs and Drug Addiction Agency (EMCDDA or the Agency). 1.
International Drug Policy Consortium submission for the evaluation of Council Framework Decision 2004/757/JHA The International Drug Policy Consortium (IDPC) is thankful for the opportunity to comment on the Council Framework Decision 2004/757/JHA. 1. Move away from eradication goals The Framework Decision aims to reduce the availability of illicit drugs.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put International Drug Policy Consortium next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Is this your organization?
Everything on this page comes from International Drug Policy Consortium’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.